Cargando…
Burden of illness among patients with dementia-related psychosis
BACKGROUND: More than 5.6 million Americans suffer from dementia, and that number is expected to double by 2060. This comes at a considerable burden to the health care system with costs estimated at $157-$215 billion in 2010. Depending on dementia type and disease progression, approximately 20%-70%...
Autores principales: | Frazer, Monica, Abler, Victor, Halpern, Rachel, Skoog, Ben, Rashid, Nazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391020/ https://www.ncbi.nlm.nih.gov/pubmed/33645238 http://dx.doi.org/10.18553/jmcp.2021.27.3.367 |
Ejemplares similares
-
Real-World Medication Treatment Patterns for Long-Term Care Residents with Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2021) -
Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2022) -
Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study
por: Rashid, Nazia, et al.
Publicado: (2022) -
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
por: Yunusa, Ismaeel, et al.
Publicado: (2022) -
Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
por: Abler, Victor, et al.
Publicado: (2022)